3 posts on this topic, sorted most recent first.
The London private GLP-1 market has fragmented since the NHS Wegovy expansion in late 2025. Here's the current operational state of who's prescribing, what they charge, and which path is wrong for whom.
What changed for UK GLP-1 access since the April 2026 buyer's guide. NHS QOF tirzepatide indicators went live April 1; Cohort 2 (BMI 35-39.9) starts June; oral Wegovy 25mg shipped at private pharmacies in January; Foundayo (orforglipron) MHRA pathway tracked. Private market still dominant. What to do today.
Numan, Voy, Juniper, Boots, Asda, Pharmacy2U, ZAVA, Second Nature. Per-dose pricing, MHRA posture, what the rubric scores them on, and how to pick the right one for your situation.